Balloon Pulmonary Angioplasty (BPA)

PROCEDURE2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Amsterdam UMC, location VUmc

Conditions

Chronic Thromboembolic DiseaseChronic Thromboembolic Pulmonary Hypertension

Unknown Phase

Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension

CompletedNCT02634203

Assistance Publique - Hôpitaux de ParisChronic Thromboembolic Pulmonary Hypertension

Start: 2016-01-19End: 2020-01-27Updated: 2021-01-26

BPA in CTEPD Without PH

RecruitingNCT06090838

Amsterdam UMC, location VUmcChronic Thromboembolic Disease

Start: 2023-06-15End: 2027-10-31Target: 60Updated: 2023-10-19

Related Papers

Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial

Circulation Cardiovascular Interventions2025-02-015 citations

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Clinical Outcomes.

2023-04-053 citations

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.

2022-08-01134 citations

Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.

2021-12-271 citations

Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study

BMJ Open2020-02-0120 citations

Balloon pulmonary angioplasty: does it have a role in CTED?

Pulmonary Circulation2018-01-0110 citations